PEAK6 LLC

Position in INSM — INSMED Inc

CIK 1389958 AUSTIN, TX

Back to INSM Full portfolio

Position in INSM

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$1,296,059

-$2,565,888 QoQ

Shares Held

7,926

-64.3% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2025

3 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in INSM Over Time

Shares Held

Position Value (USD)

Derivatives in INSM

reported options exposure · as of Mar 31, 2026

CallValue

CallShares

PutValue

$2,305,632

PutShares

14,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

PEAK6 LLC holds $24,388,144 across 19 Biotechnology names. INSM ranks #7 (5.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CRSP	CRISPR Therapeutics AG	108,604	$5,166,292
2	BNTX	BioNTech SE	43,054	$3,826,639
3	ALNY	Alnylam Pharmaceuticals, Inc.	9,716	$3,214,732
4	MRNA	Moderna, Inc.	60,583	$3,077,616
5	IONS	Ionis Pharmaceuticals Inc	34,419	$2,584,522
6	REGN	Regeneron Pharmaceuticals, Inc.	2,955	$2,283,150
7	INSM	INSMED Inc This page	7,926	$1,296,059
8	DNA	Ginkgo Bioworks Holdings, Inc.	107,163	$656,909

All Filings in INSM

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,305,632	14,100	+77.9%	Put	Defined	2026-05-14
2026-03-31	$1,296,059	7,926	-54.2%	Shares	Defined	2026-05-14
2025-12-31	$3,010,892	17,300	-22.0%	Call	Defined	2026-03-12
2025-12-31	$3,861,947	22,190	+824.6%	Shares	Defined	2026-03-12
2025-12-31	$417,696	2,400	-65.7%	Put	Defined	2026-03-12
2025-09-30	$1,008,070	7,000	-95.8%	Put	Defined	2026-03-31
2025-09-30	$23,977,665	166,500	—	Call	Defined	2026-03-31
No filing history on record for this holder in this stock.